Dr Amy Chung is a lead of the Discovery Science cross-cutting discipline at the Doherty Institute. She completed her PhD at the University of Melbourne in 2011 and conducted a postdoc at the Ragon Institute of Massachussetts General Hospital (MGH), Massachussetts Institute of Technology (MIT) and Harvard. She returned to the University of Melbourne in 2015 and established her own laboratory in 2019. Her research focuses upon the application of cutting-edge experimental technologies to holistically examine functional antibodies against a range of infectious diseases including HIV, Mycobacterium Tuberculosis, Malaria and Influenza. This research can be used to design future antibody-based vaccines and can contribute to the generation of improved monoclonal antibody therapeutics.